SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $309,000 | -90.9% | 13,009 | -86.6% | 0.01% | -87.8% |
| Q1 2019 | $3,407,000 | +121.1% | 97,242 | +109.7% | 0.07% | +85.0% |
| Q4 2018 | $1,541,000 | +20.1% | 46,376 | +65.5% | 0.04% | +48.1% |
| Q1 2018 | $1,283,000 | -39.3% | 28,015 | -46.6% | 0.03% | -41.3% |
| Q4 2017 | $2,115,000 | +123.3% | 52,461 | +120.8% | 0.05% | +155.6% |
| Q3 2017 | $947,000 | -55.7% | 23,758 | -65.2% | 0.02% | -65.4% |
| Q1 2017 | $2,137,000 | +170.8% | 68,285 | +118.6% | 0.05% | +85.7% |
| Q4 2016 | $789,000 | -75.4% | 31,244 | -75.9% | 0.03% | -71.7% |
| Q3 2016 | $3,211,000 | -43.4% | 129,825 | -53.4% | 0.10% | -47.1% |
| Q2 2016 | $5,676,000 | +8.9% | 278,668 | -18.4% | 0.19% | +25.5% |
| Q1 2016 | $5,210,000 | -2.6% | 341,626 | -12.6% | 0.15% | +18.3% |
| Q4 2015 | $5,351,000 | +35.7% | 390,994 | +39.2% | 0.13% | +1.6% |
| Q3 2015 | $3,942,000 | -67.4% | 280,966 | -60.5% | 0.12% | -62.1% |
| Q2 2015 | $12,075,000 | +1269.0% | 711,129 | +875.0% | 0.33% | +1386.4% |
| Q1 2015 | $882,000 | – | 72,939 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |